These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7975827)

  • 21. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice.
    Welkos SL; Friedlander AM
    Microb Pathog; 1988 Aug; 5(2):127-39. PubMed ID: 3148815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy assessment of a triple anthrax chimeric antigen as a vaccine candidate in guinea pigs: challenge test with
    Abdous M; Hasannia S; Salmanian AH; Arab SS
    Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):495-502. PubMed ID: 34259590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of spore surface antigens in the genus Bacillus by the use of polyclonal antibodies in immunofluorescence tests.
    Phillips AP; Martin KL
    J Appl Bacteriol; 1988 Jan; 64(1):47-55. PubMed ID: 3127370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity.
    Turnbull PC; Broster MG; Carman JA; Manchee RJ; Melling J
    Infect Immun; 1986 May; 52(2):356-63. PubMed ID: 3084381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine.
    Marcus H; Danieli R; Epstein E; Velan B; Shafferman A; Reuveny S
    Infect Immun; 2004 Jun; 72(6):3471-7. PubMed ID: 15155654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax.
    Peterson JW; Comer JE; Noffsinger DM; Wenglikowski A; Walberg KG; Chatuev BM; Chopra AK; Stanberry LR; Kang AS; Scholz WW; Sircar J
    Infect Immun; 2006 Feb; 74(2):1016-24. PubMed ID: 16428748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
    Ndumnego OC; Köhler SM; Crafford J; van Heerden H; Beyer W
    Vet Immunol Immunopathol; 2016 Oct; 178():14-21. PubMed ID: 27496738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced Immune Response to DNA Vaccine Encoding Bacillus anthracis PA-D4 Protects Mice against Anthrax Spore Challenge.
    Kim NY; Chang DS; Kim Y; Kim CH; Hur GH; Yang JM; Shin S
    PLoS One; 2015; 10(10):e0139671. PubMed ID: 26430894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of the protective antigen of Bacillus anthracis on the formation of immunity under the action of live anthrax vaccines].
    Abalakin VA; Buravtseva NP; Cherkasskiĭ BL
    Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):72-5. PubMed ID: 2117320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers.
    McBride BW; Mogg A; Telfer JL; Lever MS; Miller J; Turnbull PC; Baillie L
    Vaccine; 1998 May; 16(8):810-7. PubMed ID: 9627938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
    Mendelson I; Gat O; Aloni-Grinstein R; Altboum Z; Inbar I; Kronman C; Bar-Haim E; Cohen S; Velan B; Shafferman A
    Vaccine; 2005 Dec; 23(48-49):5688-97. PubMed ID: 16039760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen.
    Aloni-Grinstein R; Gat O; Altboum Z; Velan B; Cohen S; Shafferman A
    Infect Immun; 2005 Jul; 73(7):4043-53. PubMed ID: 15972492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.
    Baillie LW; Rodriguez AL; Moore S; Atkins HS; Feng C; Nataro JP; Pasetti MF
    Vaccine; 2008 Nov; 26(48):6083-91. PubMed ID: 18805452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A putative exosporium lipoprotein GBAA0190 of Bacillus anthracis as a potential anthrax vaccine candidate.
    Jeon JH; Kim YH; Kim KA; Kim YR; Woo SJ; Choi YJ; Rhie GE
    BMC Immunol; 2021 Mar; 22(1):20. PubMed ID: 33743606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge.
    Coulson NM; Fulop M; Titball RW
    Vaccine; 1994 Nov; 12(15):1395-401. PubMed ID: 7887017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.
    Cote CK; Rossi CA; Kang AS; Morrow PR; Lee JS; Welkos SL
    Microb Pathog; 2005; 38(5-6):209-25. PubMed ID: 15925272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis.
    Yin Y; Zhang J; Dong D; Liu S; Guo Q; Song X; Li G; Fu L; Xu J; Chen W
    Vaccine; 2008 Oct; 26(46):5814-21. PubMed ID: 18786589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge.
    Sivko GS; Stark GV; Tordoff KP; Taylor KL; Glaze E; VanRaden M; Schiffer JM; Hewitt JA; Quinn CP; Nuzum EO
    Vaccine; 2016 Dec; 34(51):6518-6528. PubMed ID: 27155494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays.
    Mabry R; Brasky K; Geiger R; Carrion R; Hubbard GB; Leppla S; Patterson JL; Georgiou G; Iverson BL
    Clin Vaccine Immunol; 2006 Jun; 13(6):671-7. PubMed ID: 16760326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.
    Peterson JW; Comer JE; Baze WB; Noffsinger DM; Wenglikowski A; Walberg KG; Hardcastle J; Pawlik J; Bush K; Taormina J; Moen S; Thomas J; Chatuev BM; Sower L; Chopra AK; Stanberry LR; Sawada R; Scholz WW; Sircar J
    Infect Immun; 2007 Jul; 75(7):3414-24. PubMed ID: 17452469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.